Define clinical exposure associated with QTc liability

Data Card

Define clinical exposure associated with QTc liabilityEarly cardiac derisking: A clinically translatable hiPSC cardiomyocyte assay

Achieve action potential recordings from intrinsically paced hiPSC-CMs with Metrion’s clinically predictive hiPSC cardiomyocyte assay.

  • Simultaneous high-resolution measurement across 96 well plate at 10,000 Hz
  • Recordings using voltage-sensitive dye equivalent in quality to patch clamp
  • Multiple endpoints evaluated (APD20/50/90, rise time, beat rate, triangulation)
  • Measurement of acute (30min) and chronic (24h/48h) effects
  • Predicts clinical exposure associated with 10ms QTc prolongation
  • Defines exposure associated with QRS probability
  • Highlights unknown acute/chronic toxicity

Read more about our hiPSC cardiomyocyte assay.

Contact us for a quote or discussion



Recommended Publications
Latest Publications
Robust Sensory Neuron Phenotype Identified in Human iPSC-derived Sensory Neurons using Electrophysioloigcal Recordings

The presence of sensory neuron markers, excitability properties consistent with sensory neurons, and evidence of nociceptor ion channels (using both RNASeq and electrophysiology) provides strong evidence that iCell Sensory Neurons have a robust sensory neuron phenotype suitable for supporting pain discovery programs.

Validation of Antibody Toxin Fusions Against Sodium Channels

Using automated patch clamp technology, we evaluate the potency and selectivity of ten Nav1.7-selective arachnid peptide toxins, which have been fused to the C-terminus (Fc region) of human IgG1.

View All
Metrion is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram